Stay updated on Navarixin and Pembrolizumab Combination Clinical Trial
Sign up to get notified when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.

Latest updates to the Navarixin and Pembrolizumab Combination Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the earlier notices for v3.4.1 and the government funding status message.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding lapse notice about NIH operations and updated the page to revision v3.4.1. The previous revision v3.4.0 was removed.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary toggle is now visible, and the page metadata has been updated to include a new 'Last Update Submitted that Met QC Criteria' entry and a revised revision to v3.4.0, along with the addition of a 'No FEAR Act Data' note; the previous QC label, FEAR Act data label, and the older v3.3.4 revision were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision notes show v3.3.4 added and v3.3.3 removed, indicating a minor behind-the-scenes update rather than changes to study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check64 days agoChange DetectedA new Locations section lists additional study sites in the United States, Australia, Canada, and Israel, expanding where the trial is available. The HHS Vulnerability Disclosure link and several location-specific pages were removed as part of a site cleanup.SummaryDifference1%

- Check85 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; no other changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Navarixin and Pembrolizumab Combination Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Navarixin and Pembrolizumab Combination Clinical Trial page.